USPTO serial 79312246
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lawrence H. Binderow, Attorney at Law
Lawrence H. Binderow, Attorney at Law BINDEROW LAW OFFICES1330 Camino Del MarSuite 250Del Mar, CA 92014| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Acne cleansers, being pharmaceutical preparations for the treatment of acne; pharmaceutical preparations for the treatment of promoting healthy skin, hair and nails and the treatment of dermatological conditions; stimulants made of minerals, namely, pharmaceutical preparations for stimulating healthy skin and hair growth, promoting healthy skin and treating dermatological conditions; stimulants made of vitamins, namely, pharmaceutical preparations for stimulating healthy skin and hair growth, promoting healthy skin and treating dermatological conditions; pharmaceutical substances for the treatment of promoting healthy skin, hair and nails and the treatment of dermatological conditions; collagen based medicated supplements, namely, dietary supplements; collagen for medical purposes; medicated dermatological creams; medicated dermatological preparations; medicated dermatological substances in the form of ointments for dermatological conditions; medicated external dermatological preparations; antiseptic cleansers; medicated skin cleansers; medicated soap; antibacterial soap; medicinal ointments for treating dermatological conditions; medicated creams for treating dermatological conditions; medicated lotions for treating dermatological conditions; medicated moisturisers being pharmaceutical preparations for skin care; medicated skin care preparations; medicated skin care products, namely, medicated skin care preparations; natural body care products for the face, namely, medicated facial cleansers, lotions and moisturisers; natural body care products for the skin, namely, medicated skin cleansers, lotions and moisturisers; natural healthcare preparations, namely, medicaments for treating skin conditions; medicated preparations for the treatment of the skin; dietary supplements; antioxidants being dietary supplements; dietary food supplements; dietary nutritional supplements for medical purposes; dietary protein supplements; dietary supplements with a cosmetic effect; dietetic food supplements adapted for medical purposes; enzyme dietary supplements; dietary fibre to aid digestion; food supplements for medical purposes; herbal dietary supplements for human consumption; medicated food supplements; medicated preparations for use as supplements for food, namely, medicated food supplements; medicated supplements for foodstuffs for human consumption, namely, medicated food supplements; medicinal food supplements; mineral dietary supplements for humans; mineral food supplements; mineral preparations for use as supplements to drinking water for medical purposes; nutritional drinks being dietary food supplements; nutritional supplement energy bars; nutritional supplement protein bars; nutritional supplements; nutritional supplements for medical use; nutritional meal replacements in the form of bars, beverages and drink mixes adapted for medical use; medical plant compounds for use as dietary supplements; plant extracts being dietary supplements; powdered whey protein being dietary supplements; powdered whey protein being nutritional supplements; vitamin supplements; dietary preparations being medical preparations for slimming purposes; beverages fortified with vitamins for medical purposes; effervescent vitamin tablets; vitamins; vitamin drinks, namely, vitamin fortified beverages for medical purposes; vitamin preparations; probiotic bacterial formulations for medical use, namely, probiotic preparations for medical use; probiotic bacterial preparations, namely, probiotic preparations for medical use; capsules of herbs for medical use; extracts of medicinal herbs, namely, medicinal herb extracts; herb preparations for medicinal purposes, namely, medicinal herbal preparations; herbs for medicinal purposes; infusions for medicinal purposes made from herbs, namely, medicinal infusions for treating dermatological conditions; extracts of plants in capsule form for pharmaceutical use; beverages containing added minerals, namely, mineral fortified beverages for medical purposes; medicated mineral drinks; medicated mineral spring waters for the treatment of dermatological conditions; mineral additives, namely, mineral preparations for medical purposes and mineral supplements; medicated mineral salts for baths; mineral salts for medical use; mineral salts for pharmaceutical use in the treatment of dermatological conditions; mineral spring salt for medical purposes; mineral water salts for medical purposes; mineral waters for medical purposes; mineral waters for medicinal purposes; natural mineral water for medical purposes; preparations of minerals for medical purposes; digestants being digestives for pharmaceutical purposes; digestive enzymes for medical purposes; enzyme preparations for medical purposes; enzymes for medical purposes; protein preparations for use as additives to foodstuffs for human consumption being protein supplements adapted for medical purposes; waters for medical purposes, namely, medicated water for the treatment of dermatological conditions | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 14, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 14, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 14, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 10, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 20, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 20, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 7, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 7, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 7, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 29, 2022 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Apr 1, 2022 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Feb 15, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 15, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 14, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 26, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 26, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 26, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 12, 2022 | ALIE | ASSIGNED TO LIE | — |
| Jan 12, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 12, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 12, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 12, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 12, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 26, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 24, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 23, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 23, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 3, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 3, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 1, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 31, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 24, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 9, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 5, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 3, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |